-
YICAI | Asieris Soars as China Approves World's First Non-Invasive Treatment for Cervical Precancerous Lesions
Shares of Asieris Pharmaceuticals soared by their daily trading limit after China granted the drugmaker marketing approval for Cevira, the world's first non-surgical, non-invasive treatment for cervical precancerous lesions caused by high-risk human papillomavirus... -
China Fund News | STAR Market Pharmaceutical Companies Intensively Disclose R&D Progress: Yahong Meditech' Globally First-in-Class Product Approved for Marketing
On the evening of March 3, 6 biopharmaceutical companies listed on the STAR Market, including Yahong Meditech, Bio-Thera Solutions, and Hinova Pharmaceuticals, collectively disclosed progress in drug registration and R&D... -
People's Financial News | Four STAR Market Companies Disclose Operating Data: Strong Start to the Year of the Horse
On the evening of March 3, four companies listed on the STAR Market—BIWIN Storage, Allist Pharmaceuticals, Zhuhai CosMX, and V-Test Semiconductor—released their latest operating data since the beginning of the year... -
People's Financial News | Four STAR Market Companies Disclose Operating Data: Strong Start to the Year of the Horse
On the evening of March 3, four companies listed on the STAR Market—BIWIN Storage, Allist Pharmaceuticals, Zhuhai CosMX, and V-Test Semiconductor—released their latest operating data since the beginning of the year... -
Shanghai Securities News | Raising Over RMB 1.3 Billion to Strengthen Core Business: Newway Photomask' Private Placement Application Accepted
On March 3, the Shanghai Stock Exchange newly accepted the application of Shenzhen Newway Photomask Making Co., Ltd. for a share issuance to specific investors... -
People's Financial News | STAR Market Companies Expected to Post 28.2% YoY Growth in Net Profit in 2025: Nearly 60% Report YoY Increase
As of March 2, 2026, all companies listed on the Shanghai Stock Exchange STAR Market had disclosed their 2025 annual results in the form of preliminary earnings releases or annual reports... -
YICAI | China's Frontier Biotech Pops After Granting GSK Rights to Two siRNA Drugs in USD1 Billion Deal
Shares of Frontier Biotechnologies surged after the Chinese drugmaker granted UK pharmaceutical giant GSK the exclusive global rights to two small nucleic acid therapies it is developing in a deal worth more than USD1 billion... -
Shanghai Securities News | Full of Vitality and Highlights, SSE STAR Market Companies Energize the Spring Festival Consumer Market with Technology
During the Spring Festival holiday, companies listed on the SSE STAR Market have activated new vitality in the Spring Festival consumer market through an innovative "technology commerce" model...